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Increasing number of medical tourists travel internationally for cosmetic procedures. Lipotourism is a form of medical tourism
becoming popular among patients of developed countries due to the cost efficiency of cosmetic procedures when performed in
developing nations.There is a paucity of data on quality, safety, and risks involvedwith these surgeries.Many cases of infections have
been documented in patients following cosmetic surgeries in developing countries. We present a case of a 34-year-old female who
underwent abdominoplasty in Dominican Republic that was complicated with development of multiple abdominal wall abscesses
due to infection from rapidly growing mycobacteria (RGM). In the absence of clear treatment guidelines, she was treated with a
combination of intermittent surgical drainage and prolonged antibiotic course. This case is of interest as more than one species of
RGMwas isolated from the same patient. Our case highlights the fact that identification of these organisms can be difficult requiring
referral of samples to specialized laboratories and treatment duration can last several months, which is determined by clinical and
microbiological response.
1. Introduction
Travel to developing nations for cheaper surgical procedures
is getting popular in the form of medical tourism. Mod-
ernization of technology, medicine, and medical facilities in
low-income countries, access to information via Internet,
and efficient air travel are facilitating this phenomenon
[1]. Majority of these surgical procedures are for cosmetic
reasons and body fat removal; thus, this practice is often
termed lipotourism [2]. Surgeries performed in these set-
tings are often complicated with skin and surgical site
infections. Legal protection of medical tourists is usually
absent due to inadequate malpractice laws in the destina-
tion countries [1]. Rapidly growing mycobacteria (RGM)
has been associated with skin and surgical site infections
in patients returning from cosmetic surgical procedures
overseas [3–5]. We present another case of such infection
caused by M. chelonae-abscessus complex and M. fortuitum
complex.
2. Case Presentation
A 34-year-old female with past medical history significant for
abdominoplasty in Dominican Republic three weeks prior to
presentation came to our hospital with complaints of redness
and swelling in the epigastric region. She developed abdom-
inal discomfort a few days after she left the hospital and this
progressed slowly over the weeks. Pertinent negative history
included absence of nausea, vomiting, diarrhea, fever, chills,
chest pain, shortness of breath, or changes in bowel habits.
She also denied recent illness, sick contacts, or exposures.
On arrival to the Emergency Department, her vitals were
stable with blood pressure of 99/65mmHg, pulse rate of
100 beats per minute, and respiratory rate of 20 per minute.
Her body temperature was 36.8∘C and she saturated 98%
in room air. Physical examination revealed an erythematous
tender indurated area in the epigastrium approximately 2 cm
in diameter. Complete blood count revealed a hemoglobin
of 9.1 g/dl and white blood cell count of 13.7 × 109 per
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Figure 1: CT abdomen and pelvis with intravenous contrast show-
ing large subcutaneous collection in the anterior abdominal wall
(blue arrow) suggestive of abscess.
Figure 2: Soft, fluctuant, erythematous, and tender swelling in the
lateral aspect of left hip.
liter (L) with 73% neutrophils. Both Erythrocyte Sedimen-
tation Rate (ESR) and C-Reactive Protein (CRP) were ele-
vated at 33mm/hr and 2.3mg/dL, respectively. Comprehen-
sive metabolic panel was within normal limits. Computed
Tomography (CT) of the abdomen and pelvis with contrast
noted a large subcutaneous collection in the anterior abdom-
inal wall suggestive of abdominal wall seroma (Figure 1).
It also showed multiple areas of increased attenuation over
the subcutaneous tissues of the abdomen, lower back, and
bilateral flanks. Patient underwent CT guided drainage with
placement of a drain in the anterior abdominal wall. During
the procedure a sample of cloudy, straw colored fluid was sent
for aerobic, anaerobic, and acid-fast bacilli (AFB) cultures.
Ziehl-Neelsen stain was positive and rapid growth was
detected in the AFB culture media. Samples were sent to Yale
New Haven Hospital Laboratory for further identification.
After 16 s rRNA sequencing analysis, the isolate was identified
asMycobacterium fortuitum complex. Patient was started on
oral levofloxacin and doxycycline and discharged home with
outpatient follow-up.
Two weeks later, she returned with two new soft tender
swellings in her left lateral hip (Figure 2) and low mid back
(Figure 3). A repeat CT abdomen and pelvis revealed signifi-
cant resolution of the anterior abdominal wall fluid collection
Figure 3: Soft, fluctuant, erythematous, and tender swelling in the
lower central back (upper border of the tattoo).
Figure 4: CT abdomen and pelvis with intravenous contrast
showing subcutaneous rim-enhancing lesion in the left flank (blue
arrow) suggestive of an abscess.
and subcutaneous rim-enhancing collection in the left flank
suggestive of developing abscesses along with multiple other
developing abscesses (Figure 4). She underwent incision and
drainage and surgical debridement of the abdominal wall
abscesses. Each abscess was incised at the pointed area with
maximal threat of tissue breakdown. Incision was followed
by immediate egress of pus under pressure. It was yellow,
thick, and creamy, and a culture swab was taken of this for
aerobic and anaerobic infection. Each wound was opened
further and the wound cavity was cleaned by pulse irrigation.
The wounds were then dressed using Iodoform gauze and
ABD pads and secured with a Tegaderm with Mastisol used
to keep the Tegaderm in place. She was started on empiric
intravenous (IV) antibiotics (meropenem and amikacin) and
moxifloxacin. Susceptibilities forM. fortuitum complex were
ordered at the National Jewish Health Laboratory in Denver.
New fluid samples collected during the second drainage were
sent to the State of Connecticut’s laboratory for identification.
After two weeks of intravenous antibiotics, IV amikacin
was discontinued to avoid its adverse effects including
interstitial nephritis, renal tubular necrosis, and ototoxic-
ity. Doxycycline was added to the treatment with moxi-
floxacin and intravenous meropenem. The National Jewish
Health laboratory identifiedMycobacterium senegalense (one
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of the species that belongs to Mycobacterium fortuitum
complex) by rpoB gene sequencing. The Mycobacterium
was sensitive to amikacin, kanamycin, cefoxitin, imipenem,
ciprofloxacin, doxycycline, moxifloxacin, tigecycline, clar-
ithromycin, and azithromycin. It was noted to be resistant to
sulfamethoxazole-trimethoprim, augmentin, and linezolid.
After a total of twenty-one days of IV antibiotics, patient was
discharged home on clarithromycin, doxycycline, and moxi-
floxacin. Final cultures from the second debridement iden-
tified M. chelonae-abscessus group using chemotaxonomic
testing (high performance liquid chromatography (HPLC));
susceptibilities were not obtained. Patient has been on a
regular follow-up with the infectious disease physician for
seven months with slow progressive resolution of abdominal
lesions.
3. Discussion
International travel in search of affordable health care or
medical tourism is becoming very popular. Our patient
travelled from United States to Dominican Republic with the
aim of getting a cosmetic procedure for body fat removal.
Lipotourism is a terminology used to describe practice of such
travel for cosmetic surgeries for removal of body fat [5]. This
practice has its financial benefits at the cost of other untoward
risks. Data on quality, safety, and risks involved with these
surgeries is lacking. Infections with RGM have been reported
in cosmetic surgeries performed in the developing nations
including Latin America and Caribbean. Increasing number
of cases are also reported in Europe due to lipotourism to
Eastern and Southern Europe [1, 2]. Most of the prior reports
have foundM. abscessus to be responsible for these infections.
Nontuberculous Mycobacteria (NTM) or atypical myco-
bacteria encompass a group of acid-fast organisms of
mycobacteria species apart fromMycobacterium tuberculosis
and Mycobacterium leprae. With advance in isolation and
identification methods, there have been increasing incidence
and reports of infections caused by this bacterial species
ranging from skin and soft tissue infections to pulmonary
and disseminated disease. Depending on the growth rate,
NTM can be classified into rapidly growing mycobacteria
(RGM) and slowly growing mycobacteria (SGM). RGM
obtain their name from rapid growth in culture media
within seven days. This group is subdivided into six different
complexes based on genetic relatedness and pigmentation:
Mycobacterium fortuitum, Mycobacterium chelonae/absces-
sus, Mycobacterium mucogenicum, Mycobacterium smeg-
matis, early pigmenting RGM, and nonpigmented RGM [6, 7].
Mycobacterium fortuitum, Mycobacterium chelonae, and
Mycobacterium abscessus are three species of RGM responsi-
ble for the majority of clinical cases of skin and soft tissue
infections in the United States [6]. Patients affected by M.
chelonae usually have a predisposing immune suppression,
while patients affected by M. fortuitum are immunocom-
petent patients that have suffered a trauma or an open
laceration. M. abscessus can affect both normal hosts and
immunocompromised patients [7]. Clinical findings of RGM
are usually nonspecific and variable. Because of this variabil-
ity in presentation, a high index of suspicion is required to
diagnose skin infections caused by RGM.M. chelonae andM.
abscessus usually present with multiple skin lesions. Severe
and disseminated cutaneous disease ismost commonwithM.
chelonae. Classic presentation of skin infection caused byM.
fortuitum is a single subcutaneous nodule at the site of trauma
or surgery [6].
NTMare environmental bacteria that are found in natural
and treated waters, soils, aerosols, and animals. Biofilms
protect these mycobacteria from eradication by ordinary dis-
infection processes [6]. NTM are responsible for a wide array
of infections, ranging from skin and soft tissue infections
to osteomyelitis, pulmonary infections, and disseminated
disease. Humans get infected by exposure to environmental
reservoirs [8]. Skin and soft tissue infections result from
colonization of mycobacteria by direct inoculation acquired
via trauma, surgery, drug injections, and animal bites [3, 4, 6].
We believe that our patient was infected during her cosmetic
procedure, since it has been shown that water supplies in
hospitals can act as a reservoir leading to contamination
of surgical instruments, irrigation solutions, and injectable
medicines [6].
Diagnosis is established by biopsy of the skin lesions
and abscess followed by cultures and histopathology. Gram
stains and regular cultures usually do not yield any results
and specific stains and cultures for mycobacteria are required
[6, 9, 10]. RGMare specially sensitive to decontamination and
discoloration procedures; therefore, it is difficult to rule out
RGM infection with a negative smear [8]. Our patient had
two different species of RGM isolated from different body
locations, collected weeks apart. These varying results may
reflect a true infection by different pathogenic RGMor simply
an error in identification.We believe that she had a true infec-
tion and she was colonized by both bacteria species during
her surgery in Dominican Republic. Our theory is further
supported by the fact that the second set of cultures was
obtained from lesions that were already developing on the
first abdominal imaging. Also, the absence of any prior sur-
gical soft tissue infections by RGM at our institution makes
us less suspicious about an acquired infection while at our
facility.Thus, this case reports coinfection by different rapidly
growing mycobacteria after abdominoplasty. However, we
want to acknowledge the possibility of an identification error
since different techniques were used and HPLC has more
limitations compared to molecular sequencing (discussion
about identification techniques and its limitations is beyond
the purpose of this article) [8].
Treatment usually requires a multidisciplinary approach
and includes a combination of antibiotics with surgical
drainage of abscess. There is no consensus in treatment and
there are no prior well-controlled trials to guide treatment.
RGM are susceptible to oral antibiotics: macrolides (clar-
ithromycin, azithromycin), fluoroquinolones (ciprofloxacin,
levofloxacin, and moxifloxacin), tetracyclines (doxycycline,
minocycline), linezolid, and trimethoprim-sulfamethoxazole
[10–12]. M. fortuitum is more susceptible to drugs than M.
chelonae or M. abscessus. Due to emergence of resistance
and failure of treatment, monotherapy with a single agent
is not recommended. Options for parenteral therapy include
amikacin, imipenem, and levofloxacin [13, 14]. Treatment
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duration and route of administration are variable depending
on site, severity of infection, and microbiological and clinical
response. It is important to monitor drug toxicity while
administering these antibiotics with regular follow-up of
liver function, renal panel, and assessment of auditory and
vestibular function [10]. Our patient has completed seven
months of oral antibiotics with good response.
In summary, we present a case of a 34-year-old woman
who acquired a soft tissue infection caused by RGM after an
abdominoplasty overseas. Inmedical tourists presenting with
infections following cosmetic surgery performed overseas,
RGM should always be included in microbiological workup.
Factors pointing towards the diagnosis of RGM include lack
of response to conventional antibiotic regimen, recurrent
wound infections, wound dehiscence, and poor wound heal-
ing as seen in our patient. Identification of these organisms
can be difficult and referral of samples to specialized lab-
oratories may be needed. Even though there are no clear
guidelines, our patient responded well to a combination of
antibiotic treatment and surgical debridement. Treatment
can last several months and must be determined by clinical
and microbiological response. What is unique about our case
is the isolation of two different RGM species, which could
have presented a treatment challenge in terms of antibiotic
sensitivities. With this case, it is also important to raise
awareness among physicians as well as general public about
the risks involved with medical procedures performed in
developing countries to avoid these complications.
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